Bacterial resistance to antimicrobial peptides
- PMID: 31637796
- DOI: 10.1002/psc.3210
Bacterial resistance to antimicrobial peptides
Abstract
Antimicrobial peptides (AMPs) or host defense peptides (HDPs) are vital components of human innate defense system targeting human-related bacteria. Many bacteria have various mechanisms interfering with AMP activity, causing resistance to AMPs. Since AMPs are considered as potential novel antimicrobial drugs, understanding the mechanisms of bacterial resistance to direct killing of AMPs is of great significance. In this review, a comparative overview of bacterial strategies for resistance to direct killing of various AMPs is presented. Such strategies include bacterial cell envelope modification, AMP degradation, sequestration, expelling, and capsule.
Keywords: AMPs; antimicrobial peptides; bacterial resistance; host defense peptides.
© 2019 European Peptide Society and John Wiley & Sons, Ltd.
References
REFERENCES
-
- Devine DA, Hancock RE. Cationic peptides: distribution and mechanisms of resistance. Curr Pharm Des. 2002;8(9):703-714.
-
- Sun E, Belanger CR, Haney EF, Hancock RE. Host defense (antimicrobial) peptides. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Elsevier. 2018;253-285.
-
- Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol. 2006;8(1):11.
-
- Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother. 1999;43(6):1317-1323.
-
- Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis. 2001;1(3):156-164.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical